CTS Trials Network: A paradigm shift in the surgical treatment of moderate ischemic mitral regurgitation? | Zendy

Ahmed Afifi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

CTS Trials Network: A paradigm shift in the surgical treatment of moderate ischemic mitral regurgitation?

Author(s) -

Ahmed Afifi

Publication year - 2015

Publication title -

global cardiology science and practice

Language(s) - English

Resource type - Journals

ISSN - 2305-7823

DOI - 10.5339/gcsp.2015.30

Subject(s) - medicine , cardiology , mitral regurgitation , clinical endpoint , bypass grafting , randomized controlled trial , clinical trial , mitral valve repair , artery , mitral valve , surgery

The Cardiothoracic Surgery Trials Network has reported results of the one-year follow up of their randomized trial "Surgical Treatment of Moderate Ischemic Mitral Regurgitation". They studied 301 patients with moderate ischemic mitral regurgitation (IMR) undergoing coronary artery bypass grafting (CABG) with or without mitral repair with the primary end-point of change in left ventricular end-diastolic volume index (LVEDVI) at one year and multiple clinical and echocardiographic secondary endpoints. Although their results were against repairing the mitral valve, the debate on surgical management of moderate IMR remains unsettled.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research